| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |